<VariationArchive VariationID="53072" VariationName="NM_000218.3(KCNQ1):c.573_577del (p.Arg192fs)" VariationType="Deletion" Accession="VCV000053072" Version="55" RecordType="classified" NumberOfSubmissions="17" NumberOfSubmitters="16" DateLastUpdated="2024-06-23" DateCreated="2014-11-22" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="67740" VariationID="53072">
      <GeneList>
        <Gene Symbol="KCNQ1" FullName="potassium voltage-gated channel subfamily Q member 1" GeneID="3784" HGNC_ID="HGNC:6294" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11p15.5-15.4</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="2445008" stop="2849105" display_start="2445008" display_stop="2849105" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NT_187585.1" start="1031" stop="81270" display_start="1031" display_stop="81270" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="2466220" stop="2870339" display_start="2466220" display_stop="2870339" Strand="+" />
          </Location>
          <OMIM>607542</OMIM>
          <Haploinsufficiency last_evaluated="2020-10-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=KCNQ1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-10-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=KCNQ1">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000218.3(KCNQ1):c.573_577del (p.Arg192fs)</Name>
      <CanonicalSPDI>NC_000011.10:2570719:GCTGCGCT:GCT</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11p15.5</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="2570720" stop="2570724" display_start="2570720" display_stop="2570724" variantLength="5" positionVCF="2570719" referenceAlleleVCF="GGCTGC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="2591950" stop="2591954" display_start="2591950" display_stop="2591954" variantLength="5" positionVCF="2591949" referenceAlleleVCF="GGCTGC" alternateAlleleVCF="G" />
      </Location>
      <OtherNameList>
        <Name>NP_000209.2:p.Arg518Ter</Name>
      </OtherNameList>
      <ProteinChange>R192fs</ProteinChange>
      <ProteinChange>R65fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181798.1" sequenceAccession="NM_181798" sequenceVersion="1" change="c.192_196delGCGCT">
            <Expression>NM_181798.1:c.192_196delGCGCT</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.2570723_2570727del" Assembly="GRCh38">
            <Expression>NC_000011.10:g.2570723_2570727del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.2591953_2591957del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.2591953_2591957del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008935.1" sequenceAccession="NG_008935" sequenceVersion="1" change="g.130733_130737del">
            <Expression>NG_008935.1:g.130733_130737del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000218.2" sequenceAccession="NM_000218" sequenceVersion="2" change="c.573_577delGCGCT">
            <Expression>NM_000218.2:c.573_577delGCGCT</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000209.2" sequenceAccession="NP_000209" sequenceVersion="2" change="p.Arg192Cysfs">
            <Expression>NP_000209.2:p.Arg192Cysfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000218.3" sequenceAccession="NM_000218" sequenceVersion="3" change="c.573_577del" MANESelect="true">
            <Expression>NM_000218.3:c.573_577del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000209.2" sequenceAccession="NP_000209" sequenceVersion="2" change="p.Arg192fs">
            <Expression>NP_000209.2:p.Arg192fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001406836.1" sequenceAccession="NM_001406836" sequenceVersion="1" change="c.573_577delGCGCT">
            <Expression>NM_001406836.1:c.573_577delGCGCT</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001393765.1" sequenceAccession="NP_001393765" sequenceVersion="1" change="p.Arg192Cysfs">
            <Expression>NP_001393765.1:p.Arg192Cysfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001406837.1" sequenceAccession="NM_001406837" sequenceVersion="1" change="c.303_307delGCGCT">
            <Expression>NM_001406837.1:c.303_307delGCGCT</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001393766.1" sequenceAccession="NP_001393766" sequenceVersion="1" change="p.Arg102Cysfs">
            <Expression>NP_001393766.1:p.Arg102Cysfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181798.2" sequenceAccession="NM_181798" sequenceVersion="2" change="c.192_196delGCGCT">
            <Expression>NM_181798.2:c.192_196delGCGCT</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_861463.1" sequenceAccession="NP_861463" sequenceVersion="1" change="p.Arg65Cysfs">
            <Expression>NP_861463.1:p.Arg65Cysfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_040711.2" sequenceAccession="NR_040711" sequenceVersion="2" change="n.466_470delGCGCT">
            <Expression>NR_040711.2:n.466_470delGCGCT</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_287" sequenceAccession="LRG_287">
            <Expression>LRG_287:g.130733_130737del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_287t1" sequenceAccession="LRG_287t1">
            <Expression>LRG_287t1:c.573_577del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_287p1" sequenceAccession="LRG_287p1" change="p.Arg192fs">
            <Expression>LRG_287p1:p.Arg192fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_287t2" sequenceAccession="LRG_287t2">
            <Expression>LRG_287t2:c.192_196del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_287p2" sequenceAccession="LRG_287p2" change="p.Arg65fs">
            <Expression>LRG_287p2:p.Arg65fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA007559" DB="ClinGen" />
        <XRef Type="rs" ID="397508118" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000218.3(KCNQ1):c.573_577del (p.Arg192fs) AND Jervell and Lange-Nielsen syndrome 1" Accession="RCV000144973" Version="7">
        <ClassifiedConditionList TraitSetID="799">
          <ClassifiedCondition DB="MedGen" ID="C4551509">Jervell and Lange-Nielsen syndrome 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no classification provided</ReviewStatus>
            <Description SubmissionCount="1">not provided</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000218.3(KCNQ1):c.573_577del (p.Arg192fs) AND not provided" Accession="RCV000182268" Version="17">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-01-17" SubmissionCount="4">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000218.3(KCNQ1):c.573_577del (p.Arg192fs) AND Long QT syndrome" Accession="RCV000233139" Version="17">
        <ClassifiedConditionList TraitSetID="8775">
          <ClassifiedCondition DB="MedGen" ID="C0023976">Long QT syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-12-07" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000218.3(KCNQ1):c.573_577del (p.Arg192fs) AND Cardiovascular phenotype" Accession="RCV000590377" Version="8">
        <ClassifiedConditionList TraitSetID="32616">
          <ClassifiedCondition DB="MedGen" ID="CN230736">Cardiovascular phenotype</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-01-17" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000218.3(KCNQ1):c.573_577del (p.Arg192fs) AND multiple conditions" Accession="RCV000602841" Version="8">
        <ClassifiedConditionList TraitSetID="48420">
          <ClassifiedCondition DB="MedGen" ID="C1141890">Congenital long QT syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0022387">Jervell and Lange-Nielsen syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-06-28" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000218.3(KCNQ1):c.573_577del (p.Arg192fs) AND Long QT syndrome 1" Accession="RCV000853261" Version="7">
        <ClassifiedConditionList TraitSetID="797">
          <ClassifiedCondition DB="MedGen" ID="C4551647">Long QT syndrome 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-03-23" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000218.3(KCNQ1):c.573_577del (p.Arg192fs) AND multiple conditions" Accession="RCV001258104" Version="5">
        <ClassifiedConditionList TraitSetID="9137">
          <ClassifiedCondition DB="MedGen" ID="C4551509">Jervell and Lange-Nielsen syndrome 1</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C4551647">Long QT syndrome 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-10-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000218.3(KCNQ1):c.573_577del (p.Arg192fs) AND KCNQ1-related disorder" Accession="RCV003335078" Version="1">
        <ClassifiedConditionList TraitSetID="33473">
          <ClassifiedCondition DB="MedGen" ID="CN239322">KCNQ1-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000218.3(KCNQ1):c.573_577del (p.Arg192fs) AND Cardiac arrhythmia" Accession="RCV003591643" Version="1">
        <ClassifiedConditionList TraitSetID="32411">
          <ClassifiedCondition DB="MedGen" ID="C0003811">Cardiac arrhythmia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-05-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-07" NumberOfSubmissions="17" NumberOfSubmitters="16" DateCreated="2014-11-22" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10560595</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">10704188</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">10973849</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">11140949</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">11530100</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15840476</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18452873</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19862833</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22539601</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22677073</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23392653</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23631430</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24666684</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25471708</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25991456</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27451284</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30369311</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30406014</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31246743</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31520628</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32893267</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9323054</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9328483</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301579</ID>
          <ID Source="BookShelf">NBK1405</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="48420" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18758" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Familial long QT syndrome</ElementValue>
                <XRef ID="MONDO:0019171" DB="MONDO" />
                <XRef ID="768" DB="Orphanet" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Congenital long QT syndrome</ElementValue>
                <XRef ID="442917000" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Romano-Ward syndrome</ElementValue>
                <XRef ID="Romano-Ward+syndrome/9638" DB="Genetic Alliance" />
                <XRef ID="20852007" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ventricular fibrillation with prolonged QT interval</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">RWS</ElementValue>
                <XRef Type="MIM" ID="192500" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">WRS</ElementValue>
                <XRef Type="MIM" ID="192500" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16547" />
                <XRef ID="16547" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="101016" DB="Orphanet" />
              <XRef ID="768" DB="Orphanet" />
              <XRef ID="C1141890" DB="MedGen" />
              <XRef ID="MONDO:0019171" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS192500" DB="OMIM" />
            </Trait>
            <Trait ID="34624" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Jervell and Lange-Nielsen syndrome</ElementValue>
                <XRef ID="MONDO:0002441" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS220400" DB="OMIM" />
                <XRef ID="373905003" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Jervell-Lange Nielsen syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">JLNS</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3048" />
                <XRef ID="3048" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Jervell and Lange-Nielsen syndrome (JLNS) is characterized by congenital profound bilateral sensorineural hearing loss and long QTc, usually &gt;500 msec. Prolongation of the QTc interval is associated with tachyarrhythmias, including ventricular tachycardia, episodes of torsade de pointes ventricular tachycardia, and ventricular fibrillation, which may culminate in syncope or sudden death. Iron-deficient anemia and elevated levels of gastrin are also frequent features of JLNS. The classic presentation of JLNS is a deaf child who experiences syncopal episodes during periods of stress, exercise, or fright. Fifty percent of individuals with JLNS had cardiac events before age three years. More than half of untreated children with JLNS die before age 15 years.</Attribute>
                <XRef ID="NBK1405" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301579</ID>
                <ID Source="BookShelf">NBK1405</ID>
              </Citation>
              <XRef ID="90647" DB="Orphanet" />
              <XRef ID="C0022387" DB="MedGen" />
              <XRef ID="MONDO:0002441" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS220400" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="33473" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="36519" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">KCNQ1-Related Disorders</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">KCNQ1-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">KCNQ1-related disorder</ElementValue>
              </Name>
              <XRef ID="CN239322" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="32616" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33389" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Cardiovascular phenotype</ElementValue>
              </Name>
              <XRef ID="CN230736" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="32411" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1082" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Cardiac arrhythmia</ElementValue>
                <XRef ID="698247007" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cardiac rhythm disease</ElementValue>
                <XRef ID="MONDO:0007263" DB="MONDO" />
              </Name>
              <XRef ID="C0003811" DB="MedGen" />
              <XRef ID="EFO_0004269" DB="EFO" />
              <XRef ID="MONDO:0007263" DB="MONDO" />
              <XRef Type="primary" ID="HP:0011675" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0001656" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0001661" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0001665" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0001666" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0001687" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0001721" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0004351" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0005158" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9137" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2703" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Long QT syndrome 1</ElementValue>
                <XRef ID="Long+QT+syndrome+1/4297" DB="Genetic Alliance" />
                <XRef ID="MONDO:0008646" DB="MONDO" />
                <XRef ID="MONDO:0100316" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LQT1</ElementValue>
                <XRef ID="GTR000558497" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="192500" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Long QT syndrome (LQTS) is a cardiac electrophysiologic disorder, characterized by QT prolongation and T-wave abnormalities on the EKG that are associated with tachyarrhythmias, typically the ventricular tachycardia torsade de pointes (TdP). TdP is usually self-terminating, thus causing a syncopal event, the most common symptom in individuals with LQTS. Such cardiac events typically occur during exercise and emotional stress, less frequently during sleep, and usually without warning. In some instances, TdP degenerates to ventricular fibrillation and causes aborted cardiac arrest (if the individual is defibrillated) or sudden death. Approximately 50% of untreated individuals with a pathogenic variant in one of the genes associated with LQTS have symptoms, usually one to a few syncopal events. While cardiac events may occur from infancy through middle age, they are most common from the preteen years through the 20s. Some types of LQTS are associated with a phenotype extending beyond cardiac arrhythmia. In addition to the prolonged QT interval, associations include muscle weakness and facial dysmorphism in Andersen-Tawil syndrome (LQTS type 7); hand/foot, facial, and neurodevelopmental features in Timothy syndrome (LQTS type 8); and profound sensorineural hearing loss in Jervell and Lange-Nielson syndrome.</Attribute>
                <XRef ID="NBK1129" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3284" />
                <XRef ID="3284" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301308</ID>
                <ID Source="BookShelf">NBK1129</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="general" Abbrev="HRS/EHRA, 2012">
                <ID Source="PubMed">21810866</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <XRef ID="101016" DB="Orphanet" />
              <XRef ID="768" DB="Orphanet" />
              <XRef ID="C4551647" DB="MedGen" />
              <XRef ID="MONDO:0100316" DB="MONDO" />
              <XRef Type="MIM" ID="192500" DB="OMIM" />
            </Trait>
            <Trait ID="5349" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Deafness, congenital, and functional heart disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Prolonged QT interval in EKG and sudden death</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cardioauditory syndrome of Jervell and Lange-Nielsen</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Surdo-cardiac syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Jervell and Lange-Nielsen syndrome 1</ElementValue>
                <XRef ID="MONDO:0024540" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">JLNS1</ElementValue>
                <XRef Type="MIM" ID="220400" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">Jervell and Lange-Nielsen Syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Jervell and Lange-Nielsen syndrome (JLNS) is characterized by congenital profound bilateral sensorineural hearing loss and long QTc, usually &gt;500 msec. Prolongation of the QTc interval is associated with tachyarrhythmias, including ventricular tachycardia, episodes of torsade de pointes ventricular tachycardia, and ventricular fibrillation, which may culminate in syncope or sudden death. Iron-deficient anemia and elevated levels of gastrin are also frequent features of JLNS. The classic presentation of JLNS is a deaf child who experiences syncopal episodes during periods of stress, exercise, or fright. Fifty percent of individuals with JLNS had cardiac events before age three years. More than half of untreated children with JLNS die before age 15 years.</Attribute>
                <XRef ID="NBK1405" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301579</ID>
                <ID Source="BookShelf">NBK1405</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2002">
                <ID Source="pmc">3110944</ID>
              </Citation>
              <XRef ID="768" DB="Orphanet" />
              <XRef ID="90647" DB="Orphanet" />
              <XRef ID="C4551509" DB="MedGen" />
              <XRef ID="MONDO:0024540" DB="MONDO" />
              <XRef Type="MIM" ID="220400" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="799" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="5349" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Deafness, congenital, and functional heart disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Prolonged QT interval in EKG and sudden death</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cardioauditory syndrome of Jervell and Lange-Nielsen</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Surdo-cardiac syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Jervell and Lange-Nielsen syndrome 1</ElementValue>
                <XRef ID="MONDO:0024540" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">JLNS1</ElementValue>
                <XRef Type="MIM" ID="220400" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">Jervell and Lange-Nielsen Syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Jervell and Lange-Nielsen syndrome (JLNS) is characterized by congenital profound bilateral sensorineural hearing loss and long QTc, usually &gt;500 msec. Prolongation of the QTc interval is associated with tachyarrhythmias, including ventricular tachycardia, episodes of torsade de pointes ventricular tachycardia, and ventricular fibrillation, which may culminate in syncope or sudden death. Iron-deficient anemia and elevated levels of gastrin are also frequent features of JLNS. The classic presentation of JLNS is a deaf child who experiences syncopal episodes during periods of stress, exercise, or fright. Fifty percent of individuals with JLNS had cardiac events before age three years. More than half of untreated children with JLNS die before age 15 years.</Attribute>
                <XRef ID="NBK1405" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301579</ID>
                <ID Source="BookShelf">NBK1405</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2002">
                <ID Source="pmc">3110944</ID>
              </Citation>
              <XRef ID="768" DB="Orphanet" />
              <XRef ID="90647" DB="Orphanet" />
              <XRef ID="C4551509" DB="MedGen" />
              <XRef ID="MONDO:0024540" DB="MONDO" />
              <XRef Type="MIM" ID="220400" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="8775" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16506" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Long QT syndrome</ElementValue>
                <XRef ID="Long+QT+Syndrome/4296" DB="Genetic Alliance" />
                <XRef ID="MONDO:0002442" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS192500" DB="OMIM" />
                <XRef ID="9651007" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LQTS</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">LQT</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="mode of inheritance">Various modes of inheritance</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000520458" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000555634" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552174" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522197" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528497" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000511116" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592276" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520456" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000523361" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000519089" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522200" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528536" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520446" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528500" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520478" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558315" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000515873" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552322" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520063" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501111" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000525920" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000559512" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591169" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Long QT syndrome (LQTS) is a cardiac electrophysiologic disorder, characterized by QT prolongation and T-wave abnormalities on the EKG that are associated with tachyarrhythmias, typically the ventricular tachycardia torsade de pointes (TdP). TdP is usually self-terminating, thus causing a syncopal event, the most common symptom in individuals with LQTS. Such cardiac events typically occur during exercise and emotional stress, less frequently during sleep, and usually without warning. In some instances, TdP degenerates to ventricular fibrillation and causes aborted cardiac arrest (if the individual is defibrillated) or sudden death. Approximately 50% of untreated individuals with a pathogenic variant in one of the genes associated with LQTS have symptoms, usually one to a few syncopal events. While cardiac events may occur from infancy through middle age, they are most common from the preteen years through the 20s. Some types of LQTS are associated with a phenotype extending beyond cardiac arrhythmia. In addition to the prolonged QT interval, associations include muscle weakness and facial dysmorphism in Andersen-Tawil syndrome (LQTS type 7); hand/foot, facial, and neurodevelopmental features in Timothy syndrome (LQTS type 8); and profound sensorineural hearing loss in Jervell and Lange-Nielson syndrome.</Attribute>
                <XRef ID="NBK1129" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301308</ID>
                <ID Source="BookShelf">NBK1129</ID>
              </Citation>
              <Citation Type="general" Abbrev="AHRQ, 2013">
                <ID Source="BookShelf">NBK248310</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="HRS/EHRA/APHRS, 2013">
                <ID Source="PubMed">23994779</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <XRef ID="C0023976" DB="MedGen" />
              <XRef ID="D008133" DB="MeSH" />
              <XRef ID="MONDO:0002442" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="797" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2703" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Long QT syndrome 1</ElementValue>
                <XRef ID="Long+QT+syndrome+1/4297" DB="Genetic Alliance" />
                <XRef ID="MONDO:0008646" DB="MONDO" />
                <XRef ID="MONDO:0100316" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LQT1</ElementValue>
                <XRef ID="GTR000558497" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="192500" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Long QT syndrome (LQTS) is a cardiac electrophysiologic disorder, characterized by QT prolongation and T-wave abnormalities on the EKG that are associated with tachyarrhythmias, typically the ventricular tachycardia torsade de pointes (TdP). TdP is usually self-terminating, thus causing a syncopal event, the most common symptom in individuals with LQTS. Such cardiac events typically occur during exercise and emotional stress, less frequently during sleep, and usually without warning. In some instances, TdP degenerates to ventricular fibrillation and causes aborted cardiac arrest (if the individual is defibrillated) or sudden death. Approximately 50% of untreated individuals with a pathogenic variant in one of the genes associated with LQTS have symptoms, usually one to a few syncopal events. While cardiac events may occur from infancy through middle age, they are most common from the preteen years through the 20s. Some types of LQTS are associated with a phenotype extending beyond cardiac arrhythmia. In addition to the prolonged QT interval, associations include muscle weakness and facial dysmorphism in Andersen-Tawil syndrome (LQTS type 7); hand/foot, facial, and neurodevelopmental features in Timothy syndrome (LQTS type 8); and profound sensorineural hearing loss in Jervell and Lange-Nielson syndrome.</Attribute>
                <XRef ID="NBK1129" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3284" />
                <XRef ID="3284" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301308</ID>
                <ID Source="BookShelf">NBK1129</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="general" Abbrev="HRS/EHRA, 2012">
                <ID Source="PubMed">21810866</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <XRef ID="101016" DB="Orphanet" />
              <XRef ID="768" DB="Orphanet" />
              <XRef ID="C4551647" DB="MedGen" />
              <XRef ID="MONDO:0100316" DB="MONDO" />
              <XRef Type="MIM" ID="192500" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="9030192" SubmissionDate="2024-04-16" DateLastUpdated="2024-04-20" DateCreated="2024-04-20">
        <ClinVarSubmissionID localKey="1522779|MONDO:0002442" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004838759" DateUpdated="2024-04-20" DateCreated="2024-04-20" Type="SCV" Version="1" SubmitterName="All of Us Research Program, National Institutes of Health" OrgID="509529" OrganizationCategory="consortium" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10704188</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11530100</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22539601</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24666684</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25471708</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27451284</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30369311</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30406014</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31246743</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31520628</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32893267</ID>
          </Citation>
          <Comment>This variant (also known as 572del5 and c.572_576del in published literature due to the use of alternate nomenclature) deletes 5 nucleotides in exon 3 of the KCNQ1 gene, creating a frameshift and premature translation stop signal. This variant is expected to result in an absent or non-functional protein product. A functional study has shown that this variant does not produce any significant potassium current and has a mild dominant negative effect when co-expressed with wild-type KCNQ1 channels in Xenopus laevis oocytes (PMID: 11530100). This variant has been reported in homozygous or compound heterozygous states in many individuals affected with Jervell and Lange-Nielsen syndrome from 15 different families of Norwegian or Swedish ancestry, and in heterozygous state in 3 relatives affected with long QT syndrome and in 29 asymptomatic relatives from these families (PMID: 10704188, 22539601, 25471708, 27451284, 30406014). This variant has also been reported in another 8 unrelated individuals affected with long QT syndrome (PMID: 24666684, 30369311, 31246743, 31520628, 32893267). This variant has been identified in 4/249462 chromosomes in the general population by the Genome Aggregation Database (gnomAD). Loss of KCNQ1 function is a known mechanism of disease (clinicalgenome.org). Based on the available evidence, this variant is classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <NumberTested>108544</NumberTested>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="5" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="5" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNQ1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.2591953_2591957del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0002442" />
          </Trait>
        </TraitSet>
        <Comment>This study involves interpretation of variants in research participants for the purpose of population health screening. Participant phenotype was not available at the time of variant classification. Additional details can be found in publication PMID: 35346344, PMCID: PMC8962531</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB14382316</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1808521" SubmissionDate="2018-08-15" DateLastUpdated="2019-06-30" DateCreated="2019-06-30">
        <ClinVarSubmissionID localKey="KCNQ1 p.Arg192Cysfs*91|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000924822" DateUpdated="2019-06-30" DateCreated="2019-06-30" Type="SCV" Version="1" SubmitterName="Stanford Center for Inherited Cardiovascular Disease, Stanford University" OrgID="505443" OrganizationCategory="clinic" OrgAbbreviation="SCICD" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-09-22">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>Testing was performed by GeneDx. Weve seen this variant in adult in our center with likely long QT syndrome Given the type of variation, the rarity, and the case data we consider this variant likely pathogenic and we do feel it is suitable for assessing risk in healthy relatives ("predictive genetic testing"). There are multiple nonsense and frameshift mutations resulting in premature stop codons listed as pathogenic in HGMD and in the NYU/IRCCS Fondazione Salvatore Maugeri Inherited Arrhythmias Database. Of note, ExAC data suggests KCNQ1 is not tolerant to loss of function variation. Fewer variants of that type are observed in the ExAC data than expected. In Familion's case series, 15% of 199 KCNQ1 variants identified on long QT testing were loss of function (Kapplinger et al 2009). Priori's original series had similar rates (Napolitano et al 2005). We have seen multiple loss of function variants in KCNQ1 that we feel are pathogenic. The variant was reported online in 4 of 59916 individuals in the Exome Aggregation Consortium dataset (http://exac.broadinstitute.org/), which currently includes variant calls on ~64,000 individuals of European, African, Latino and Asian descent (as of Sep 22nd, 2016). Specifically, the variant was observed in 4 of 32851 Europeans. The phenotype of those individuals is not publicly available. The dataset is comprised of multiple cohorts, some of which were recruited from the general population, others were enriched for common cardiovascular disease. Of note, given the observed Norwegian founder effect the allele frequency in a European sample is not necessarily concerning, since Norwegians may well be included in that sample.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>provider interpretation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNQ1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000218.2:c.573_577delGCGCT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB4405235</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1954641" SubmissionDate="2019-09-20" DateLastUpdated="2019-10-20" DateCreated="2019-10-20">
        <ClinVarSubmissionID localKey="c.573_577delGCGCT" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000996087" DateUpdated="2019-10-20" DateCreated="2019-10-20" Type="SCV" Version="1" SubmitterName="Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego" OrgID="506081" OrganizationCategory="laboratory" OrgAbbreviation="RCIGM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-11-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This frameshifting variant is predicted to lead to early termination of the KCNQ1 protein. There are multiple reports of the variant by clinical laboratories as pathogenic in ClinVar (Variation ID 53072) and in the literature (PMID: 24666684, 11530100, 10560595). Truncating variants in KCNQ1 are established as disease causing, and the variant is predicted by in silico methods to be damaging. Functional characterization of the variant indicated electrophysiological consequences on channel functioning (PMID: 11530100). It is seen in 2 heterozygotes in gnomAD, thus the variant is rare. Based on the combined evidence, the variant is classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SampleLocalID">187</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNQ1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000218.2:c.573_577delGCGCT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">LONG QT SYNDROME 1</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6324741</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1412761" SubmissionDate="2019-03-21" DateLastUpdated="2018-04-09" DateCreated="2018-04-09">
        <ClinVarSubmissionID localKey="74917551|Orphanet:ORPHA768;ORPHA90647" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000731601" DateUpdated="2018-04-09" DateCreated="2018-04-09" Type="SCV" Version="1" SubmitterName="Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine" OrgID="21766" OrganizationCategory="laboratory" OrgAbbreviation="LMM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-06-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">24666684</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10560595</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10704188</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11530100</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22539601</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23631430</ID>
          </Citation>
          <Comment>The p.Arg192CysfsX91 variant is reported to be a Scandinavian founder variant in KCNQ1 and has been identified in the homozygous or compound heterozygous state in at least 10 individuals from 9 families with Jervell and Lange-Nielsen syndro me (JLNS). Most of the older relatives who were heterozygous carriers of this va riant were asymptomatic with normal QT intervals, while at least 3 had clinical features of long QT syndrome (LQTS; Tranebjareg 1999, Winbo 2012), indicating re duced penetrance. This variant has also been identified in at least 4 unrelated individuals with LQTS (Ackerman 1999, Lieve 2013, Anderson 2015) and has been re ported in ClinVar (Variation ID: 53072). In vitro functional studies provide som e evidence that the p.Arg192CysfsX91 variant may slightly impact protein functio n (Huang 2001). Additionally, this variant has been identified in 4/113014 of Eu ropean chromosomes by gnomAD (http://gnomad.broadinstitute.org). This variant is predicted to cause a frameshift, which alters the protein?s amino acid sequence beginning at position 192 and leads to a premature termination codon 91 amino a cids downstream. This alteration is then predicted to lead to a truncated or abs ent protein. Loss-of-function variants in KCNQ1 are associated with LQTS (also k nown as Romano-Ward syndrome) in the heterozygous state and with JLNS in the com pound heterozygous or homozygous state. In summary, this variant meets criteria to be classified as pathogenic for LQTS in an autosomal dominant manner with red uced penetrance and JLNS in an autosomal recessive manner. ACMG/AMP criteria: PV S1, PS4, PM2.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LMM Criteria</Attribute>
          <Citation>
            <ID Source="PubMed">24033266</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="1" />
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNQ1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000218.2:EXON 3</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>NM_000218.2:c.573_577delGCGCT</Name>
            <Name>p.Arg192CysfsX91</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.2591953_2591957delGCGCT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="ORPHA768" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="ORPHA90647" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5348977</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2833354" SubmissionDate="2020-04-23" DateLastUpdated="2020-10-03" DateCreated="2020-10-03">
        <ClinVarSubmissionID localKey="NM_000218.2:c.573_577delGCGCT|Long QT syndrome 1;Jervell and Lange-Nielsen syndrome 1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001434950" DateUpdated="2020-10-03" DateCreated="2020-10-03" Type="SCV" Version="1" SubmitterName="Human Genome Sequencing Center Clinical Lab, Baylor College of Medicine" OrgID="500199" OrganizationCategory="laboratory" OrgAbbreviation="HGSC-CL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-10-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.573_577delGCGCT (p. Arg192Cysfs*91) variant in the KCNQ1 gene was predicted to produce a truncated protein. It has been observed in multiple individuals with long QT syndrome and was segregated in a Norwegian family with Long QT syndrome (PMID: 10704188, 11530100, 23392653). This variant is extremely rare in the general population according to gnomAD database. Therefore, this c.573_577delGCGCT (p. Arg192Cysfs*91) variant in the KCNQ1 gene is classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNQ1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000218.2:c.573_577delGCGCT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Long QT syndrome 1</ElementValue>
            </Name>
          </Trait>
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Jervell and Lange-Nielsen syndrome 1</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB7319360</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3879176" SubmissionDate="2021-10-29" DateLastUpdated="2021-10-30" DateCreated="2021-10-30">
        <ClinVarSubmissionID localKey="NM_000218.2:c.573_577delGCGCT|OMIM:192500" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001984981" DateUpdated="2021-10-30" DateCreated="2021-10-30" Type="SCV" Version="1" SubmitterName="Clinical Genetics Laboratory, Region Ostergotland" OrgID="506101" OrganizationCategory="laboratory" OrgAbbreviation="KlingenDC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-10-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>PVS1, PM2, PP5</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNQ1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000218.2:c.573_577delGCGCT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="192500" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10590550</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7569829" SubmissionDate="2023-09-19" DateLastUpdated="2023-10-21" DateCreated="2023-10-21">
        <ClinVarSubmissionID localKey="NM_000218.2:c.573_577del|KCNQ1-related disorders" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004046104" DateUpdated="2023-10-21" DateCreated="2023-10-21" Type="SCV" Version="1" SubmitterName="Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego" OrgID="506081" OrganizationCategory="laboratory" OrgAbbreviation="RCIGM" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This frameshifting variant in exon 3 of 16 introduces a premature stop codon and is therefore predicted to result in loss of normal protein function through either protein truncation or nonsense-mediated mRNA decay (NMD). This variant has been previously reported as a heterozygous change in multiple individuals with long QT syndrome (PMID: 10560595, 22539601, 24666684, 11530100, 23392653). Functional studies showed the c.573_577del (p.Arg192CysfsTer91) variant causes a dominant-negative effect on KCNQ1 function (PMID: 11530100). The c.573_577del (p.Arg192CysfsTer91) variant is present in the heterozygous state in the gnomAD population database at a frequency of 0.002% (4/249462) and thus is presumed to be rare. Based on the available evidence, the c.573_577del (p.Arg192CysfsTer91) variant is classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNQ1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000218.2:c.573_577del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">KCNQ1-related disorders</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13808474</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3963544" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2021-11-29">
        <ClinVarSubmissionID localKey="1d685d620ad456a863a2356b839afd6a0ecfe2956dcf2d7ad7432b8ea790db58|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002023217" DateUpdated="2024-02-04" DateCreated="2021-11-29" Type="SCV" Version="3" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-10-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000218.2:c.573_577del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10694847</SubmissionName>
          <SubmissionName>SUB12926214</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="539108" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2016-07-01">
        <ClinVarSubmissionID localKey="391982|MedGen:C0023976" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000283884" DateUpdated="2024-02-14" DateCreated="2016-07-01" Type="SCV" Version="11" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9323054</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19862833</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10560595</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11530100</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22539601</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23392653</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24666684</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Arg192Cysfs*91) in the KCNQ1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in KCNQ1 are known to be pathogenic (PMID: 9323054, 19862833). This variant is present in population databases (rs764567762, gnomAD 0.003%). This premature translational stop signal has been observed in individual(s) with long QT syndrome (PMID: 10560595, 11530100, 22539601, 23392653, 24666684). ClinVar contains an entry for this variant (Variation ID: 53072). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNQ1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.2591950_2591954del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0023976" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28492532</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8042384" SubmissionDate="2024-01-25" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="Db4KrQBSZeoE7-orUyypkTM3AutVWtzy1MyU8rV-8EA|MedGen:C0003811" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004358376" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Color Diagnostics, LLC DBA Color Health" OrgID="505849" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10704188</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22539601</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24666684</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25471708</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27451284</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30369311</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30406014</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31246743</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31520628</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32893267</ID>
          </Citation>
          <Comment>This variant (also known as 572del5 and c.572_576del in published literature due to the use of alternate nomenclature) deletes 5 nucleotides in exon 3 of the KCNQ1 gene, creating a frameshift and premature translation stop signal. This variant is expected to result in an absent or non-functional protein product. This variant has been reported in homozygous or compound heterozygous states in many individuals affected with Jervell and Lange-Nielsen syndrome from 15 different families of Norwegian or Swedish ancestry, and in heterozygous state in 3 relatives affected with long QT syndrome and in 29 asymptomatic relatives from these families (PMID: 10704188, 22539601, 25471708, 27451284, 30406014). This variant has also been reported in another 8 unrelated individuals affected with long QT syndrome (PMID: 24666684, 30369311, 31246743, 31520628, 32893267). This variant has been identified in 4/249462 chromosomes in the general population by the Genome Aggregation Database (gnomAD). Loss of KCNQ1 function is a known mechanism of disease (clinicalgenome.org). Based on the available evidence, this variant is classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <TypePlatform>NGS</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNQ1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000218.3:c.573_577del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0003811" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14171678</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1436384" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2018-03-17">
        <ClinVarSubmissionID localKey="a52084|MedGen:CN230736" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000737838" DateUpdated="2024-05-01" DateCreated="2018-03-17" Type="SCV" Version="6" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-01-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10560595</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10704188</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11530100</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22539601</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24666684</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9328483</ID>
          </Citation>
          <Comment>The c.573_577delGCGCT pathogenic mutation, located in coding exon 3 of the KCNQ1 gene, results from a deletion of 5 nucleotides at positions 573 to 577, causing a translational frameshift with a predicted alternate stop codon (p.R192Cfs*91). This alteration has been described in several homozygous and compound heterozygous families with autosomal recessive Jervell and Lange-Nielsen syndrome, and haplotype analysis has suggested a founder mutation effect in Norway (Tranebjaerg L et al. Am J Med Genet. 1999;89:137-46). Among these families, this alteration also was detected in the heterozygous state in multiple unaffected relatives; however, in other studies, this alteration was reported in heterozygous individuals with autosomal dominant long QT syndrome (LQTS) (Ackerman MJ et al. Mayo Clin Proc.1999;74:1088-94; Anderson HN et al. Cardiol Young. 2015;25:376-9), suggesting co-segregation with incomplete penetrance. In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNQ1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000218.2:c.573_577delGCGCT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <XRef DB="MedGen" ID="CN230736" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalAVA3AVA4ClinvarDepositThrough031523</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
          <SubmissionName>NonExomeUpdate_081220AmbryReport</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1362344" SubmissionDate="2018-01-25" DateLastUpdated="2018-03-17" DateCreated="2018-03-17">
        <ClinVarSubmissionID localKey="NM_000218.2:c.573_577delGCGCT|MedGen:CN230736" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000695992" DateUpdated="2018-03-17" DateCreated="2018-03-17" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-05-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23392653</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18452873</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10973849</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15840476</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9328483</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22677073</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22539601</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25991456</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11530100</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11140949</ID>
          </Citation>
          <Comment>Variant summary: The KCNQ1 c.573_577delGCGCT (p.Arg192Cysfs) variant results in a premature termination codon, predicted to cause a truncated or absent KCNQ1 protein due to nonsense mediated decay, which are commonly known mechanisms for disease. This variant was found in 4/120312 control chromosomes at a frequency of 0.0000332, which does not exceed the estimated maximal expected allele frequency of a pathogenic KCNQ1 variant (0.0000833). The variant is recurrently reported in patients with JLNS in homozygous as well as heterozygous state. The variant is also reported in heterozygous state in LQTS patients or in individuals suspected of LQTS diagnosis, in individuals with normal or borderline QTS prolongation, atrial fibrillation and sudden unexplained death, suggesting that clinical features associated with a heterozygous c.573_577delGCGCT variant are variable. Functional data are consistent with disease-causing role of this variant. It has also been reported as a probable founder/common mutation in Norway and Sweden causing JLNS. One clinical labs in ClinVar as well as reputable databases have classified it as pathogenic. Taken together, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
            <CitationText>LabCorp Variant Classification Summary - May 2015.docx</CitationText>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNQ1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <XRefList>
            <XRef DB="dbSNP" ID="606231414" Type="rsNumber" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000218.2:c.573_577delGCGCT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <XRef DB="MedGen" ID="CN230736" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2016-2017-variants</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1950844" SubmissionDate="2019-06-12" DateLastUpdated="2019-10-11" DateCreated="2019-10-11">
        <ClinVarSubmissionID localKey=":Chr.11_2591949_GGCTGC_G|Long QT Syndrome" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000995118" DateUpdated="2019-10-11" DateCreated="2019-10-11" Type="SCV" Version="1" SubmitterName="Center for Advanced Laboratory Medicine, UC San Diego Health, University of California San Diego" OrgID="507056" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-01-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNQ1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="11" alternateAllele="G" referenceAllele="GGCTGC" start="2591949" stop="2591954" variantLength="6" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Long QT Syndrome</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5806500</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="339825" SubmissionDate="2022-03-17" DateLastUpdated="2022-10-01" DateCreated="2014-11-22">
        <ClinVarSubmissionID localKey="NM_000218.2:c.572_576del|OMIM:220400" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV000192000" DateUpdated="2022-10-01" DateCreated="2014-11-22" Type="SCV" Version="3" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Citation>
            <ID Source="BookShelf">NBK1405</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000218.2:c.572_576del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C4551509" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11197040</SubmissionName>
          <SubmissionName>SUB11808016</SubmissionName>
          <SubmissionName>epb42-spherocytosis_4-24-2014</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="430870" SubmissionDate="2022-02-02" DateLastUpdated="2023-03-04" DateCreated="2015-07-05">
        <ClinVarSubmissionID localKey="GDXSV:220644" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000234571" DateUpdated="2023-03-04" DateCreated="2015-07-05" Type="SCV" Version="13" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" OrgAbbreviation="GDX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-01-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Observed in the heterozygous state in multiple individuals from different ethnic backgrounds with long QT syndrome (Stattin et al., 2012; Anderson et al., 2014; Seethala et al., 2015; Gaba et al., 2016); Prevalence and haplotype studies suggest it is a founder mutation in the Scandanavian population (Tyson et al., 1997; Winbo et al., 2012); Denoted in published literature as c.735_739delGCGCT, 5 bp deletion of nt 187-191, 572del5, c.572_576del, L191fs/90 and L191fs +90X, due to the use of alternate nomenclature; Not observed at significant frequency in large population cohorts (gnomAD); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Published functional studies demonstrate this variant alone did not produce any significant potassium current and had a mild dominant negative when co-expressed with wild-type KCNQ1 channels (Huang et al., 2001); Reported in ClinVar as pathogenic (ClinVar Variant ID# 53072; ClinVar); This variant is associated with the following publications: (PMID: 15466642, 8528244, 31019026, 11530100, 5923041, 26681611, 9328483, 10704188, 11140949, 23098067, 22539601, 24666684, 26675252, 27451284, 23392653, 22677073, 23631430, 19716085, 10973849, 15840476, 30406014, 30369311, 17470695, 10560595, 25471708, 25991456, 18452873, 19841300, 26318259, 31447099, 33087929, 34319147, 34411974)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNQ1" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:28401</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000218.2:c.573_577del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_51_20210925044204</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_86_20220202054204</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7259435" SubmissionDate="2023-03-23" DateLastUpdated="2023-09-09" DateCreated="2023-09-09">
        <ClinVarSubmissionID localKey="NM_000218.2:c.573_577del|OMIM:192500" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV003853457" DateUpdated="2023-09-09" DateCreated="2023-09-09" Type="SCV" Version="1" SubmitterName="Oxford Medical Genetics Laboratories, Oxford University Hospitals NHS Foundation Trust" OrgID="505647" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-03-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNQ1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000218.2:c.573_577del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="192500" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12982384</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8352256" SubmissionDate="2024-01-24" DateLastUpdated="2024-02-20" DateCreated="2024-02-20">
        <ClinVarSubmissionID localKey="3545045|MedGen:CN235283" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004564240" DateUpdated="2024-02-20" DateCreated="2024-02-20" Type="SCV" Version="1" SubmitterName="ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories" OrgID="25969" OrganizationCategory="laboratory" OrgAbbreviation="ARUP" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-01-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The KCNQ1 c.573_577delGCGCT; p.Arg192CysfsTer91 variant (rs397508118), also known as 572del5, 735-739delGCGCT, L191fs/90, or L191fs +90X, is reported in the literature in the homozygous or compound heterozygous state in several individuals and families affected with Jervell and Lange-Nielsen syndrome or in the heterozygous state in individuals with long QT syndrome (Ackerman 1999, Anderson 2015, Giudicessi 2013, Huang 2001), and is a founder variant in the Norwegian population (Tranebjaerg 1999). This variant is also reported in ClinVar (Variation ID: 53072), but is only observed on four alleles in the Genome Aggregation Database, indicating it is not a common polymorphism. This variant causes a frameshift by deleting 5 nucleotides, so it is predicted to result in a truncated protein or mRNA subject to nonsense-mediated decay. In vitro functional analyses demonstrate reduced current and a mild dominant negative effect (Huang 2001). Based on available information, this variant is considered to be pathogenic. References: Ackerman MJ et al. Swimming, a gene-specific arrhythmogenic trigger for inherited long QT syndrome. Mayo Clin Proc. 1999 Nov;74(11):1088-94. PMID: 10560595. Anderson HN et al. Marked, transient, emotion-triggered QT accentuation in an adolescent female with type 1 long QT syndrome. Cardiol Young. 2015 Feb;25(2):376-9. PMID: 24666684. Giudicessi JR and Ackerman MJ. Prevalence and potential genetic determinants of sensorineural deafness in KCNQ1 homozygosity and compound heterozygosity. Circ Cardiovasc Genet. 2013 Apr;6(2):193-200. PMID: 23392653. Huang L et al. A spectrum of functional effects for disease causing mutations in the Jervell and Lange-Nielsen syndrome. Cardiovasc Res. 2001 Sep;51(4):670-80. PMID: 11530100. Tranebjaerg L et al. Jervell and Lange-Nielsen syndrome: a Norwegian perspective. Am J Med Genet. 1999 Sep 24;89(3):137-46. PMID: 10704188.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ARUP Molecular Germline Variant Investigation Process 2024</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/xwiqgyug/arup_molecular_germline_variant_investigation_process_arup-info-0022_2024.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNQ1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.2591953_2591957del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN235283" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2023 ARUP ClinVar submission</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7259435" TraitType="Disease" MappingType="XRef" MappingValue="192500" MappingRef="OMIM">
        <MedGen CUI="C4551647" Name="Long QT syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1362344" TraitType="Finding" MappingType="XRef" MappingValue="CN230736" MappingRef="MedGen">
        <MedGen CUI="CN230736" Name="Cardiovascular phenotype" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2833354" TraitType="Disease" MappingType="Name" MappingValue="Jervell and Lange-Nielsen syndrome 1" MappingRef="Preferred">
        <MedGen CUI="C4551509" Name="Jervell and Lange-Nielsen syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3963544" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1954641" TraitType="Disease" MappingType="Name" MappingValue="LONG QT SYNDROME 1" MappingRef="Preferred">
        <MedGen CUI="C4551647" Name="Long QT syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7569829" TraitType="Disease" MappingType="Name" MappingValue="KCNQ1-related disorders" MappingRef="Preferred">
        <MedGen CUI="CN239322" Name="KCNQ1-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8042384" TraitType="Disease" MappingType="XRef" MappingValue="C0003811" MappingRef="MedGen">
        <MedGen CUI="C0003811" Name="Cardiac arrhythmia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="539108" TraitType="Disease" MappingType="XRef" MappingValue="C0023976" MappingRef="MedGen">
        <MedGen CUI="C0023976" Name="Long QT syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9030192" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0002442" MappingRef="MONDO">
        <MedGen CUI="C0023976" Name="Long QT syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="430870" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2833354" TraitType="Disease" MappingType="Name" MappingValue="Long QT syndrome 1" MappingRef="Preferred">
        <MedGen CUI="C4551647" Name="Long QT syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1436384" TraitType="Finding" MappingType="XRef" MappingValue="CN230736" MappingRef="MedGen">
        <MedGen CUI="CN230736" Name="Cardiovascular phenotype" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1808521" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="339825" TraitType="Disease" MappingType="XRef" MappingValue="C4551509" MappingRef="MedGen">
        <MedGen CUI="C4551509" Name="Jervell and Lange-Nielsen syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1412761" TraitType="Disease" MappingType="XRef" MappingValue="ORPHA90647" MappingRef="Orphanet">
        <MedGen CUI="C0022387" Name="Jervell and Lange-Nielsen syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3879176" TraitType="Disease" MappingType="XRef" MappingValue="192500" MappingRef="OMIM">
        <MedGen CUI="C4551647" Name="Long QT syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8352256" TraitType="Disease" MappingType="XRef" MappingValue="CN235283" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1412761" TraitType="Disease" MappingType="XRef" MappingValue="ORPHA768" MappingRef="Orphanet">
        <MedGen CUI="C1141890" Name="Congenital long QT syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1950844" TraitType="Disease" MappingType="Name" MappingValue="Long QT Syndrome" MappingRef="Preferred">
        <MedGen CUI="C0023976" Name="Long QT syndrome" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="3" DateDeleted="2017-12-11">SCV000074104</Accession>
        <Description>this interpretation was deleted because it was generated with an out-of-date curation method; no clinical information is available to provide a full interpretation of the variant</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

